Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,795 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
Patel NJ, Wang X, Lin M, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Williams ZK, Hanberg JS, Kawano Y, Schiff AE, Sparks JA, Wallace ZS. Patel NJ, et al. Among authors: qian g. J Rheumatol. 2024 May 1;51(5):529-537. doi: 10.3899/jrheum.2023-1092. J Rheumatol. 2024. PMID: 38428964 Free article.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron.
Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TYT, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Kawano Y, et al. Among authors: qian g. medRxiv [Preprint]. 2022 Jun 20:2022.06.19.22276599. doi: 10.1101/2022.06.19.22276599. medRxiv. 2022. PMID: 35765565 Free PMC article. Updated. Preprint.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
Qian G, Wang X, Patel NJ, Kawano Y, Fu X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Bade KJ, Srivatsan S, Williams ZK, Todd DJ, Weinblatt ME, Wallace ZS, Sparks JA. Qian G, et al. medRxiv [Preprint]. 2022 Oct 30:2022.10.27.22281629. doi: 10.1101/2022.10.27.22281629. medRxiv. 2022. PMID: 36324801 Free PMC article. Updated. Preprint.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Venkat RK, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Qian G, Bade KJ, Saavedra A, Srivatsan S, Williams ZK, Wallace ZS, Sparks JA. Venkat RK, et al. Among authors: qian g. Rheumatology (Oxford). 2023 Dec 9:kead662. doi: 10.1093/rheumatology/kead662. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38070152
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Hanberg JS, Fu X, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Zhang Y, Sparks JA, Wallace ZS. Hanberg JS, et al. Among authors: qian g. Lancet Rheumatol. 2024 Jan;6(1):e21-e30. doi: 10.1016/S2665-9913(23)00272-2. Epub 2023 Nov 15. Lancet Rheumatol. 2024. PMID: 38258675 Clinical Trial.
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study.
Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY, Wallace ZS, Sparks JA. Di Iorio M, et al. Among authors: qian g. medRxiv [Preprint]. 2022 Feb 9:2022.02.08.22270696. doi: 10.1101/2022.02.08.22270696. medRxiv. 2022. PMID: 35169813 Free PMC article. Updated. Preprint.
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19.
Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, Kowalski EN, Qian G, Shadick NA, Laffenburger D, Wallace ZS, Sparks JA, Alter G. Herman JD, et al. Among authors: qian g. medRxiv [Preprint]. 2022 Sep 26:2022.09.25.22280335. doi: 10.1101/2022.09.25.22280335. medRxiv. 2022. PMID: 36203557 Free PMC article. Preprint.
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.
Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, Kowalski EN, Qian G, Srivatsan S, Shadick NA, Rao DA, Kellman B, Mann CJ, Lauffenburger D, Wallace ZS, Sparks JA, Alter G. Herman JD, et al. Among authors: qian g. Sci Transl Med. 2023 Sep 6;15(712):eadf6598. doi: 10.1126/scitranslmed.adf6598. Epub 2023 Sep 6. Sci Transl Med. 2023. PMID: 37672567 Free PMC article.
1,795 results